Prognostic value of CALLY index in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy
Xiaoming Yin·Kui Fan·Wei Guo·Hongling Lu·Haijun Chen·Rujing Huang·HU Tingting·Li Xiao·Yunchuan Sun·Xinying He
As a novel inflammatory-nutritional biomarker, the C-reactive protein–albumin–lymphocyte (CALLY) index has demonstrated significant prognostic value in several cancer types. However, its predictive significance for patients with locally advanced non-small cell lung cancer (LA-NSCLC) treated with thoracic radiotherapy (RT) remains elusive. This study aimed to investigate the relationship between the pre/post-treatment CALLY index and the prognosis of patients with LA-NSCLC treated with thoracic R